_id

690db2c0ccc777a4e85d0c91

Ticker

ATOS

Name

Atossa Genetics Inc

Exchange

NASDAQ

Address

107 Spring Street, Seattle, WA, United States, 98104

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.atossatherapeutics.com

Description

Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.

Last Close

0.825

Volume

628554

Current Price

0.7147

Change

-13.369696969696964

Last Updated

2025-11-28T12:31:37.981Z

Image

data:image/webp;base64,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

Ipo Date

2012-11-08T00:00:00.000Z

Market Cap

100727880

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Rating

4.5

Target Price

5.6875

Strong Buy

2

Buy

2

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

4000

Gross Profit

-4000

Operating Expenses

9247000

Operating Income

-9251000

Interest Expense

-

Pretax Income

-8692000

Net Income

-8692000

Eps

-0.0672904248543393

Dividends Per Share

-

Shares Outstanding

129171424

Income Tax Expense

-

EBITDA

-8688000

Operating Margin

-

Total Other Income Expense Net

559000

Cash

51845000

Short Term Investments

-

Receivables

-

Inventories

-

Total Current Assets

55678000

Property Plant Equipment

-

Total Assets

58012000

Payables

3536000

Short Term Debt

-

Long Term Debt

-

Total Liabilities

8225000

Equity

49787000

Depreciation

4000

Change In Working Capital

1899000

Cash From Operations

-6005000

Capital Expenditures

7000

Cash From Investing

-7000

Cash From Financing

0

Net Change In Cash

-6012000

PE

-

PB

1.8542755484925784

ROE

-17.458372667563822

ROA

-14.983106943391022

FCF

-6012000

Fcf Percent

-

Piotroski FScore

1

Health Score

43

Deep Value Investing Score

4.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2.5

Net Net Investing Score

3.5

Quality Investing Score

2.5

Value Investing Score

5.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

4000

Quarters > 0 > income Statement > gross Profit

-4000

Quarters > 0 > income Statement > operating Expenses

9247000

Quarters > 0 > income Statement > operating Income

-9251000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-8692000

Quarters > 0 > income Statement > net Income

-8692000

Quarters > 0 > income Statement > eps

-0.0672904248543393

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

129171424

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-8688000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

559000

Quarters > 0 > balance Sheet > cash

51845000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

55678000

Quarters > 0 > balance Sheet > property Plant Equipment

-

Quarters > 0 > balance Sheet > total Assets

58012000

Quarters > 0 > balance Sheet > payables

3536000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

8225000

Quarters > 0 > balance Sheet > equity

49787000

Quarters > 0 > cash Flow > net Income

-8692000

Quarters > 0 > cash Flow > depreciation

4000

Quarters > 0 > cash Flow > change In Working Capital

1899000

Quarters > 0 > cash Flow > cash From Operations

-6005000

Quarters > 0 > cash Flow > capital Expenditures

7000

Quarters > 0 > cash Flow > cash From Investing

-7000

Quarters > 0 > cash Flow > cash From Financing

0

Quarters > 0 > cash Flow > net Change In Cash

-6012000

Quarters > 0 > ratios > PE

-0.0672904248543393

Quarters > 0 > ratios > PB

1.8542755484925784

Quarters > 0 > ratios > ROE

-17.458372667563822

Quarters > 0 > ratios > ROA

-14.983106943391022

Quarters > 0 > ratios > FCF

-6012000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

43

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

4000

Quarters > 1 > income Statement > gross Profit

-4000

Quarters > 1 > income Statement > operating Expenses

9040000

Quarters > 1 > income Statement > operating Income

-9040000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-8423000

Quarters > 1 > income Statement > net Income

-8423000

Quarters > 1 > income Statement > eps

-0.06520842522582085

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

129170425

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-9036000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

617000

Quarters > 1 > balance Sheet > cash

57857000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

3475000

Quarters > 1 > balance Sheet > total Current Assets

62517000

Quarters > 1 > balance Sheet > property Plant Equipment

-

Quarters > 1 > balance Sheet > total Assets

64515000

Quarters > 1 > balance Sheet > payables

2010000

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

6820000

Quarters > 1 > balance Sheet > equity

57695000

Quarters > 1 > cash Flow > net Income

-8423000

Quarters > 1 > cash Flow > depreciation

4000

Quarters > 1 > cash Flow > change In Working Capital

-481000

Quarters > 1 > cash Flow > cash From Operations

-7259000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

0

Quarters > 1 > cash Flow > net Change In Cash

-7259000

Quarters > 1 > ratios > PE

-0.06520842522582085

Quarters > 1 > ratios > PB

1.6001057760204522

Quarters > 1 > ratios > ROE

-14.599185371349337

Quarters > 1 > ratios > ROA

-13.055878477873362

Quarters > 1 > ratios > FCF

-7259000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

43

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

4000

Quarters > 2 > income Statement > gross Profit

-4000

Quarters > 2 > income Statement > operating Expenses

7414000

Quarters > 2 > income Statement > operating Income

-7414000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-6718000

Quarters > 2 > income Statement > net Income

-6718000

Quarters > 2 > income Statement > eps

-0.05200897880284962

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

129170004

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-7410000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

696000

Quarters > 2 > balance Sheet > cash

65116000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

68744000

Quarters > 2 > balance Sheet > property Plant Equipment

-

Quarters > 2 > balance Sheet > total Assets

70747000

Quarters > 2 > balance Sheet > payables

1165000

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

5425000

Quarters > 2 > balance Sheet > equity

65322000

Quarters > 2 > cash Flow > net Income

-6718000

Quarters > 2 > cash Flow > depreciation

4000

Quarters > 2 > cash Flow > change In Working Capital

192000

Quarters > 2 > cash Flow > cash From Operations

-5959000

Quarters > 2 > cash Flow > capital Expenditures

9000

Quarters > 2 > cash Flow > cash From Investing

-9000

Quarters > 2 > cash Flow > cash From Financing

0

Quarters > 2 > cash Flow > net Change In Cash

-5968000

Quarters > 2 > ratios > PE

-0.05200897880284962

Quarters > 2 > ratios > PB

1.4132727390281987

Quarters > 2 > ratios > ROE

-10.28443709623098

Quarters > 2 > ratios > ROA

-9.49580900956931

Quarters > 2 > ratios > FCF

-5968000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

43

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

4000

Quarters > 3 > income Statement > gross Profit

-4000

Quarters > 3 > income Statement > operating Expenses

7147000

Quarters > 3 > income Statement > operating Income

-7151000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-6347000

Quarters > 3 > income Statement > net Income

-6347000

Quarters > 3 > income Statement > eps

-0.05012581049297246

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

126621394

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-7147000

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

804000

Quarters > 3 > balance Sheet > cash

71084000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

74457000

Quarters > 3 > balance Sheet > property Plant Equipment

-

Quarters > 3 > balance Sheet > total Assets

76444000

Quarters > 3 > balance Sheet > payables

679000

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

4967000

Quarters > 3 > balance Sheet > equity

71477000

Quarters > 3 > cash Flow > net Income

-6347000

Quarters > 3 > cash Flow > depreciation

4000

Quarters > 3 > cash Flow > change In Working Capital

-1486000

Quarters > 3 > cash Flow > cash From Operations

-7051000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

3369000

Quarters > 3 > cash Flow > net Change In Cash

-3682000

Quarters > 3 > ratios > PE

-0.05012581049297246

Quarters > 3 > ratios > PB

1.266089935109196

Quarters > 3 > ratios > ROE

-8.879779509492563

Quarters > 3 > ratios > ROA

-8.302809900057559

Quarters > 3 > ratios > FCF

-7051000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

42

Valuation > metrics > PE

-0.0672904248543393

Valuation > metrics > PB

1.8542755484925784

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-17.458372667563822

Profitability > metrics > ROA

-15.61119293078056

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.1652037680519011

Risk > metrics > Interest Coverage

-2312.75

Risk > final Score

-9191

Risk > verdict

High

Liquidity > metrics > Current Ratio

15.746040723981901

Liquidity > metrics > Quick Ratio

15.746040723981901

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

1

Prev Risks > 1

17

Prev Risks > 2

24

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-16T22:25:46.536Z